| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0188 |
| Trial ID | NCT01967823 |
| Disease | Meningioma | Hepatocellular Carcinoma | Lung Non-Small Cell Carcinoma | Melanoma | Breast Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Phase II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes |
| Year | 2013 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 130214|13-C-0214 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||